Clinical outcomes and patient (pt) profiles in REASSURE: an observational study of radium-223 (Ra-223) in metastatic castration-resistant prostate cancer (mCRPC) - Miller, K; Higano, C; Saad, F; Sartor, O; Conti, P; George, D; Sternberg, CN; Shore, N; Sade, JP; Bellmunt, J; Smith, M; Logothetis, C; Verholen, F; Kalinovsky, J; Bayh, I; Tombal, B (Nuklearmedizin - NuclearMedicine, 2021)